Bochner Eye Institute
Toronto, Ontario, M5R 1A9, Canada
NCT Number: NCT04693702
The purpose of this study is to assess the vision improvement achieved by patients with retinal disorders who received corneal treatments by a low vision aid device.
Looking for future studies?
Notify Me50 year–100 year
All sexes
Observational
Toronto, Ontario, M5R 1A9, Canada
The purpose of this study is to assess the vision improvement achieved by patients with retinal disorders, including age-related macular degeneration and diabetic macular edema, who received corneal treatments by a low vision aid device. Patient records will be analyzed to determine measures of vision improvement including best spectacle-corrected distance visual acuity (CDVA). Analyses will include descriptive statistics and correlation between outcomes and baseline characteristics.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1 - Corneal disease or disorder in either eye 2 - Increased intraocular pressure (above 20mm Hg), glaucoma or history of glaucoma 3 - Presence or history of any other condition or finding that, in the opinion of the investigator, makes the patient unsuitable for retrospective observational study
-
Near infrared light is used to irradiate the cornea to change the modulus of small volumes of anterior stroma. The modulus change produces a change in light distribution onto the retina. Light rays are redirected from dysfunctional areas of the retina to functional areas, thereby improving patient vision.
Time frame: 12 months
Best spectacle-corrected distance visual acuity
Optimal Acuity Corporation
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04516278
Age-Related Macular Degeneration, BRVO - Branch Retinal Vein Occlusion
Tucson, Arizona, United States
View Trial DetailsNCT06708637
Age-Related Macular Degeneration, Branch Retinal Vein Occlusion With Macular Edema
Campbell, California, United States
View Trial DetailsNCT06213896
Age-Related Macular Degeneration, Cardiovascular Diseases
Antalya, Turkey (Türkiye)
View Trial DetailsNCT05615805
Age-Related Macular Degeneration, CYSTOID MACULAR EDEMA
Oklahoma City, Oklahoma, United States
View Trial Details